10 juli 2024
52 min
Our guest today is another Atlanta luminary, Dr. Marvin Whiteley, the founder and CSO of SynthBiome, Inc. Deaths are expected to increase over the next 20-30 years due to antibiotic resistant infections.
It’s common for people to go into the hospital for something innocuous, get an infection, and find that the bacterium doesn’t respond to antibiotic. There are strains infecting people outside of clinical settings, as well. As there are millions of deaths caused by this each year, the alarm bells are starting to go off because we are not developing a lot of new antibiotics.
How can this trend be stopped?
Disclaimers
The information contained in this website and podcast are purely informational and not considered investment recommendations. Tim Dougherty’s participation in Biotech Insights is separate and apart from his role as an investment advisor representative. Nothing contained herein may be construed as a recommendation or endorsement of any of the companies discussed. Tim Dougherty has no financial affiliation with any of the companies mentioned in this communication. Tim Dougherty makes no representation that the information conveyed in this material is accurate and is under no obligation to update this information as changes occur.
Lyssna på fler avsnitt från
Life Science and Biotech CEO stories
Visar 1–10 av 35 avsnitt
14 maj 2025
42 min
16 april 2025
48 min
19 mars 2025
46 min
12 februari 2025
53 min
15 januari 2025
40 min
18 december 2024
48 min
20 november 2024
35 min
16 oktober 2024
47 min
14 augusti 2024
12 min
12 juni 2024
57 min